查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
欧洲转染试剂和设备市场预测至 2030 年 - 区域分析 - 按产品、方法、应用和最终用户
市场调查报告书
商品编码
1562262

欧洲转染试剂和设备市场预测至 2030 年 - 区域分析 - 按产品、方法、应用和最终用户

Europe Transfection Reagents and Equipment Market Forecast to 2030 - Regional Analysis - by Product, Method, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 112 Pages | 订单完成后即时交付

价格

2022年欧洲转染试剂和设备市场估值为30,604万美元，预计2030年将达55,546万美元；预计 2022 年至 2030 年复合年增长率为 7.7%。

公司的策略性倡议推动欧洲转染试剂和设备市场

转染是开发病毒载体整个过程中的复杂步骤，病毒载体包括腺病毒、腺相关病毒和慢病毒。随着製造流程规模的扩大，瞬时转染也必须加强。製程设备供应商、药物开发人员和原料供应商正致力于合作开发具有成本效益、实用且可平台化的解决方案，以实现病毒载体製造流程的快速开发和规模化。在小规模上，透过计划的材料体积以及转移和混合时间，用多个质粒转染细胞变得可行。由于大多数公司仅拥有实验室级的转染经验，因此扩大规模需要工业化转染步骤的经验。然而，将製程扩大到更大水平所需的细胞培养基和转染试剂的体积可能不切实际，这强调了优化的必要性。儘管如此，近年来随着病毒载体需求的激增，扩大生产规模已变得普遍。由于大规模转染製程面临许多挑战，提高产量的最佳方法是减少製程而不是扩大製程规模。这种自上而下的方法可以清楚地识别影响工业水平过程的条件，例如转染复合物溶液的体积。这种方法也有助于流程最佳化和决策。这种提高小规模转染製程的方法的开发为欧洲转染试剂和设备市场的成长提供了机会。

欧洲转染试剂与设备市场概况

欧洲地区分为英国、德国、法国、西班牙、义大利和欧洲其他地区。到 2022 年，英国将占据最大的市场份额。英国是世界上先进疗法的研究、开发、製造、临床采用和报销的最佳生态系统之一。目前，英国正在进行超过 85 项临床试验，70 家 CGT 公司正在努力开发潜在的治疗方法。 Catapult 是一家顶级公司，一直为英国的 CGT 生态系统做出了重大贡献；它是该国参与开发试剂和设备製造流程的前五家公司之一。该公司专注于开发更智慧的自动化 CGT 製造流程，能够以最少的干预自动适应不断变化的环境和流程要求。因此，英国公司在提高生产力和降低最终产品成本方面所做的努力是推动英国细胞和基因疗法市场成长的主要因素。此外，由于持续且有针对性的研究投资，英国在欧洲细胞和基因治疗市场占据强势地位，进一步有利于市场。

此外，法国还有赛诺菲、益普森、皮尔法伯、HRA Pharma、TxCell（Sangamo Therapeutics, Inc.）等生物製药和製药巨头。这些公司参与疫苗和抗体等的开发，其产品需要冷冻干燥，这增加了对转染试剂和设备的需求。

欧洲转染试剂和设备市场收入及2030年预测（百万美元）

欧洲转染试剂和设备市场细分

欧洲转染试剂和设备市场根据产品、方法、应用、最终用户和国家进行细分。

根据产品，欧洲转染试剂和设备市场分为试剂和仪器。 2022 年，试剂细分市场将占更大份额。

从方法来看，欧洲转染试剂和设备市场分为病毒法、非病毒法和混合法。 2022 年，非病毒方法部分占最大份额。非病毒部分分为物理/机械方法和化学方法。此外，物理/机械方法细分为电穿孔、显微注射、生物弹体方法、雷射方法、磁转染和声穿孔。此外，化学方法部分又分为基于脂质体/高脂质和基于非脂质体/高脂质。

按应用划分，欧洲转染试剂和设备市场分为生物医学研究、蛋白质生产和治疗递送。 2022 年，生物医学研究领域占最大份额。

根据最终用户，欧洲转染试剂和设备市场分为学术和研究机构以及製药和生物技术公司。 2022 年，学术和研究机构领域占据了更大的份额。

依国家划分，欧洲转染试剂和设备市场分为德国、法国、英国、义大利、西班牙和欧洲其他地区。 2022年，英国将主导欧洲转染试剂和设备市场。

Fisher Scientific Inc、Promega Corp、F. Hoffmann-La Roche Ltd、Bio-Rad Laboratories Inc、Mirus Bio LLC、QIAGEN NV、Merck KGaA、Lonza Group AG、MaxCyte Inc 和 Polyplus-Transfection SA 是营运中的一些领先公司在欧洲转染试剂和设备市场。

目录

第 1 章：简介

第 2 章：执行摘要

  • 主要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：欧洲转染试剂与设备市场 - 主要市场动态

  • 欧洲转染试剂和设备市场 - 主要市场动态
  • 市场驱动因素
    • 细胞和基因疗法越来越受欢迎
    • 癌症带来的经济负担日益沉重
  • 市场限制
    • 仪器及耗材成本高
  • 市场机会
    • 将小规模流程升级为大规模流程
  • 未来趋势
    • 公司的策略倡议
  • 驱动因素和限制的影响：

第 5 章：转染试剂与设备市场 - 欧洲市场分析

  • 2022-2030年欧洲转染试剂与设备市场收入
  • 欧洲转染试剂及设备市场预测分析

第 6 章：欧洲转染试剂与设备市场分析 - 按产品

  • 试剂
  • 装置

第 7 章：欧洲转染试剂与设备市场分析 - 依方式

  • 病毒性的
  • 非病毒性
  • 杂交种

第 8 章：欧洲转染试剂和设备市场分析 - 按应用

  • 生物医学研究
  • 蛋白质生产
  • 治疗实施

第 9 章：欧洲转染试剂和设备市场分析 - 按最终用户

  • 学术及研究机构
  • 製药和生物技术公司

第 10 章：欧洲转染试剂与设备市场 - 国家分析

  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区

第 11 章：转染试剂与设备市场 - 产业格局

  • 概述
  • 2020-2023 年转染试剂和设备市场的成长策略
  • 无机成长策略
    • 概述
  • 有机成长策略
    • 概述

第 12 章：公司简介

  • Thermo Fisher Scientific Inc
  • Promega Corp
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Mirus Bio LLC
  • QIAGEN NV
  • Merck KGaA
  • Lonza Group AG
  • MaxCyte Inc
  • Polyplus-Transfection SA

第 13 章：附录

Product Code: BMIRE00030436

The Europe transfection reagents and equipment market was valued at US$ 306.04 million in 2022 and is expected to reach US$ 555.46 million by 2030; it is estimated to register at a CAGR of 7.7% from 2022 to 2030.

Strategic Initiatives by Companies Drive Europe Transfection Reagents and Equipment Market

Transfection is the complex step in the overall process of developing a viral vector, which includes adenovirus, adeno-associated virus, and lentivirus. As the manufacturing processes are scaled up, transient transfection must also be ramped up. Process equipment vendors, drug developers, and raw material suppliers are focusing on collaborations to develop cost-effective, practical, and platformizable solutions for the rapid development and scaling up of viral vector manufacturing processes. On small scales, with planned material volumes and transfer & mixing times, transfecting cells with multiple plasmids becomes feasible. Scaling up requires experience in industrializing the transfection step since most companies only have transfection experience at the lab level. However, the volume of cell-culture media and transfection reagents required for scaling up the process to a larger level can be impractical, which emphasizes the need for optimization. Nonetheless, broadening the scale of production has become common in recent years with the surging demand for viral vectors. With numerous challenges associated with large-scale transfection processes, the best approach to increase production is by reducing the process rather than scaling up the process. This top-down approach allows clear identification of the conditions that will impact the process at the industrial level such as the volume of transfection complex solution. This approach also facilitates process optimization and decision-making. The development of such approaches to ramp up the small-scale transfection processes acts as an opportunity for the growth of the Europe transfection reagents and equipment market.

Europe Transfection Reagents and Equipment Market Overview

Europe region segmented into UK, Germany, France, Spain, Italy, and Rest of Europe. United Kingdom holds the largest market share in the year 2022. The growth of the pharmaceutical industry is determined by the high-quality research and development ongoing in the country, and extensive and flourishing healthcare knowledge base. The UK is one of the world's best ecosystems for research, development, manufacturing, clinical adoption, and reimbursement of advanced therapeutics. Currently, over 85 clinical trials are ongoing in the UK, and 70 CGT companies are striving to develop potentially curative therapies. Catapult is a top company that has been contributing significantly to the CGT ecosystem in the UK; it stands as one of the top five companies involved in developing manufacturing processes of reagents and devices in the country. The company is focused on developing smarter automated CGT manufacturing processes that can automatically adapt to changing environments and process requirements with minimal intervention. Therefore, efforts made by UK-based companies to enhance productivity and reduce final product costs are the major factors driving the growth of the cell and gene therapy market in the UK. Moreover, the UK holds a strong position in the cell and gene therapy market in Europe owing to sustained and targeted investment in research, which further benefits the market.

Moreover, France has the presence of biopharmaceutical and pharmaceutical giants such as Sanofi S.A., Ipsen, Pierre Fabre, HRA Pharma, and TxCell (Sangamo Therapeutics, Inc.). These companies are involved in the development of vaccines and antibodies, among others, which require freeze-drying for their products, which contributes to the demand for transfection reagents and equipment.

Europe Transfection Reagents and Equipment Market Revenue and Forecast to 2030 (US$ Million)

Europe Transfection Reagents and Equipment Market Segmentation

The Europe transfection reagents and equipment market is segmented based on product, method, application, end user, and country.

Based on product, the Europe transfection reagents and equipment market is bifurcated into reagents and instruments. The reagents segment held a larger share in 2022.

In terms of method, the Europe transfection reagents and equipment market is segmented into viral methods, non-viral methods, and hybrid methods. The non-viral methods segment held the largest share in 2022. The viral segment is subcategorized into retrovirus, adenovirus, adeno associated virus, and herpes virus. The non-viral segment is bifurcated into physical/mechanical method and chemical method. Further, the physical/mechanical method segment is subcategorized into electroporation, microinjection, biolistic method, laser method, magnetofection, and sonoporation. Also, the chemical method segment is subcategorized into liposomal based/high lipid and non-liposomal/high lipid based.

By application, the Europe transfection reagents and equipment market is segmented into biomedical research, protein production, and therapeutic delivery. The biomedical research segment held the largest share in 2022.

Based on end user, the Europe transfection reagents and equipment market is bifurcated into academics & research institutes and pharmaceutical & biotechnology companies. The academics & research institutes segment held a larger share in 2022.

Based on country, the Europe transfection reagents and equipment market is categorized into Germany, France, the UK, Italy, Spain, and the Rest of Europe. The UK dominated the Europe transfection reagents and equipment market in 2022.

Fisher Scientific Inc, Promega Corp, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Mirus Bio LLC, QIAGEN NV, Merck KGaA, Lonza Group AG, MaxCyte Inc, and Polyplus-Transfection SA are some of the leading companies operating in the Europe transfection reagents and equipment market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Transfection Reagents and Equipment Market - Key Market Dynamics

  • 4.1 Europe Transfection Reagents and Equipment Market - Key Market Dynamics
  • 4.2 Market Drivers
    • 4.2.1 Increasing Popularity of Cell and Gene Therapy
    • 4.2.2 Growing Economic Burden of Cancer
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Instruments and Consumables
  • 4.4 Market Opportunities
    • 4.4.1 Ramping Up Small-Scale Processes to Large-Scale Processes
  • 4.5 Future Trends
    • 4.5.1 Strategic Initiatives by Companies
  • 4.6 Impact of Drivers and Restraints:

5. Transfection Reagents and Equipment Market - Europe Market Analysis

  • 5.1 Europe Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
  • 5.2 Europe Transfection Reagents and Equipment Market Forecast Analysis

6. Europe Transfection Reagents and Equipment Market Analysis - by Product

  • 6.1 Reagents
    • 6.1.1 Overview
    • 6.1.2 Reagents: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.2 Equipment
    • 6.2.1 Overview
    • 6.2.2 Equipment: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Transfection Reagents and Equipment Market Analysis - by Modality

  • 7.1 Viral
    • 7.1.1 Overview
    • 7.1.2 Viral: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.1.2.1 Retrovirus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.1.2.2 Adenovirus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.1.2.3 Adeno-Associated Virus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.1.2.4 Herpes Virus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Non-Viral
    • 7.2.1 Overview
    • 7.2.2 Non-Viral: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.2.2.1 Physical/Mechanical Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.1 Electroporation: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.2 Microinjection: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.3 Biolistic Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.4 Laser Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.5 Magnetofection: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.6 Sonoporation: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.2.2.2 Chemical Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.2.1 Liposomal Based/High Lipid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.2.2 Non-Liposomal Based/High Lipid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Hybrid
    • 7.3.1 Overview
    • 7.3.2 Hybrid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Transfection Reagents and Equipment Market Analysis - by Application

  • 8.1 Biomedical Research
    • 8.1.1 Overview
    • 8.1.2 Biomedical Research: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.2 Protein Production
    • 8.2.1 Overview
    • 8.2.2 Protein Production: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Therapeutic Delivery
    • 8.3.1 Overview
    • 8.3.2 Therapeutic Delivery: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Transfection Reagents and Equipment Market Analysis - by End Users

  • 9.1 Academic and Research Institutes
    • 9.1.1 Overview
    • 9.1.2 Academic and Research Institutes: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.2 Pharmaceutical and Biotechnological Companies
    • 9.2.1 Overview
    • 9.2.2 Pharmaceutical and Biotechnological Companies: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Transfection Reagents and Equipment Market -Country Analysis

  • 10.1 Europe: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
    • 10.1.1 Europe: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
    • 10.1.2 United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.2.1 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Product
      • 10.1.2.2 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Modality
        • 10.1.2.2.1 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Viral
        • 10.1.2.2.2 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
        • 10.1.2.2.2.1 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
        • 10.1.2.2.2.2 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
      • 10.1.2.3 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Application
      • 10.1.2.4 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by End Users
    • 10.1.3 Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.3.1 Germany: Transfection Reagents and Equipment Market Breakdown, by Product
      • 10.1.3.2 Germany: Transfection Reagents and Equipment Market Breakdown, by Modality
        • 10.1.3.2.1 Germany: Transfection Reagents and Equipment Market Breakdown, by Viral
        • 10.1.3.2.2 Germany: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
        • 10.1.3.2.2.1 Germany: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
        • 10.1.3.2.2.2 Germany: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
      • 10.1.3.3 Germany: Transfection Reagents and Equipment Market Breakdown, by Application
      • 10.1.3.4 Germany: Transfection Reagents and Equipment Market Breakdown, by End Users
    • 10.1.4 France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.4.1 France: Transfection Reagents and Equipment Market Breakdown, by Product
      • 10.1.4.2 France: Transfection Reagents and Equipment Market Breakdown, by Modality
        • 10.1.4.2.1 France: Transfection Reagents and Equipment Market Breakdown, by Viral
        • 10.1.4.2.2 France: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
        • 10.1.4.2.2.1 France: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
        • 10.1.4.2.2.2 France: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
      • 10.1.4.3 France: Transfection Reagents and Equipment Market Breakdown, by Application
      • 10.1.4.4 France: Transfection Reagents and Equipment Market Breakdown, by End Users
    • 10.1.5 Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.5.1 Italy: Transfection Reagents and Equipment Market Breakdown, by Product
      • 10.1.5.2 Italy: Transfection Reagents and Equipment Market Breakdown, by Modality
        • 10.1.5.2.1 Italy: Transfection Reagents and Equipment Market Breakdown, by Viral
        • 10.1.5.2.2 Italy: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
        • 10.1.5.2.2.1 Italy: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
        • 10.1.5.2.2.2 Italy: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
      • 10.1.5.3 Italy: Transfection Reagents and Equipment Market Breakdown, by Application
      • 10.1.5.4 Italy: Transfection Reagents and Equipment Market Breakdown, by End Users
    • 10.1.6 Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.6.1 Spain: Transfection Reagents and Equipment Market Breakdown, by Product
      • 10.1.6.2 Spain: Transfection Reagents and Equipment Market Breakdown, by Modality
        • 10.1.6.2.1 Spain: Transfection Reagents and Equipment Market Breakdown, by Viral
        • 10.1.6.2.2 Spain: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
        • 10.1.6.2.2.1 Spain: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
        • 10.1.6.2.2.2 Spain: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
      • 10.1.6.3 Spain: Transfection Reagents and Equipment Market Breakdown, by Application
      • 10.1.6.4 Spain: Transfection Reagents and Equipment Market Breakdown, by End Users
    • 10.1.7 Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.7.1 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Product
      • 10.1.7.2 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Modality
        • 10.1.7.2.1 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Viral
        • 10.1.7.2.2 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
        • 10.1.7.2.2.1 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
        • 10.1.7.2.2.2 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
      • 10.1.7.3 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Application
      • 10.1.7.4 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by End Users

11. Transfection Reagents and Equipment Market -Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Thermo Fisher Scientific Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Promega Corp
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 F. Hoffmann-La Roche Ltd
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Bio-Rad Laboratories Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Mirus Bio LLC
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 QIAGEN NV
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Merck KGaA
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Lonza Group AG
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 MaxCyte Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Polyplus-Transfection SA
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About Us

List Of Tables

  • Table 1. Europe Transfection Reagents and Equipment Market Segmentation
  • Table 2. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Product
  • Table 4. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Modality
  • Table 5. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Viral
  • Table 6. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Non-Viral
  • Table 7. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Physical/mechanical Method
  • Table 8. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Chemical Method
  • Table 9. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Application
  • Table 10. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by End Users
  • Table 11. Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Country
  • Table 12. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 13. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
  • Table 14. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
  • Table 15. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
  • Table 16. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
  • Table 17. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
  • Table 18. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 19. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
  • Table 20. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 21. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
  • Table 22. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
  • Table 23. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
  • Table 24. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
  • Table 25. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
  • Table 26. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 27. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
  • Table 28. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 29. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
  • Table 30. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
  • Table 31. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
  • Table 32. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
  • Table 33. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
  • Table 34. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 35. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
  • Table 36. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 37. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
  • Table 38. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
  • Table 39. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
  • Table 40. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
  • Table 41. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
  • Table 42. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 43. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
  • Table 44. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 45. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
  • Table 46. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
  • Table 47. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
  • Table 48. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
  • Table 49. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
  • Table 50. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 51. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
  • Table 52. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 53. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
  • Table 54. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
  • Table 55. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
  • Table 56. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
  • Table 57. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
  • Table 58. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 59. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
  • Table 60. Recent Inorganic Growth Strategies in the Transfection Reagents and Equipment Market
  • Table 61. Recent Organic Growth Strategies in The Transfection Reagents and Equipment Market

List Of Figures

  • Figure 1. Europe Transfection Reagents and Equipment Market Segmentation, by Country
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. Europe Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
  • Figure 4. Europe Transfection Reagents and Equipment Market Share (%) - by Product (2022 and 2030)
  • Figure 5. Reagents: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 6. Equipment: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Europe Transfection Reagents and Equipment Market Share (%) - by Modality (2022 and 2030)
  • Figure 8. Viral: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Retrovirus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Adenovirus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Adeno-Associated Virus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Herpes Virus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Non-Viral: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Physical/Mechanical: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Electroporation: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Microinjection: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Biolistic Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Laser Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Magnetofection: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Sonoporation: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Chemical Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Liposomal Based/High Lipid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Non-Liposomal Based/High Lipid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Hybrid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Europe Transfection Reagents and Equipment Market Share (%) - by Application (2022 and 2030)
  • Figure 26. Biomedical Research: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Protein Production: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Therapeutic Delivery: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Europe Transfection Reagents and Equipment Market Share (%) - by End Users (2022 and 2030)
  • Figure 30. Academic and Research Institutes: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Pharmaceutical and Biotechnological Companies: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. Europe: Transfection Reagents and Equipment Market- Revenue by Key Countries 2022 (US$ Million)
  • Figure 33. Europe: Transfection Reagents and Equipment Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 34. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 35. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 36. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 37. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 38. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 39. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 40. Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023